Why the study?
Does L-arginine supplementation improve flow-induced vasodilatation in isolated guinea pig hearts exposed to hyperglycaemia?
Does L-arginine supplementation improve flow-induced vasodilatation in isolated guinea pig hearts exposed to hyperglycaemia?
In isolated guinea pig hearts, increased flow-induced vasodilatation under hyperglycaemic conditions depends on an adequate supply of L-arginine to maintain sufficient formation of nitric oxide.
L-arginine supports hyperglycaemia-enhanced vasodilatation via nitric oxide in this model; hypothesis-generating, should not yet change clinical practice.
The effects of hyperglycaemia and L-arginine on flow-induced reduction of coronary artery resistance were investigated in isolated guinea pig hearts. In the presence of indomethacin, hyperglycaemia caused an increase in flow-induced vasodilatation (P < 0.05). Hyperosmotic controls failed to mimic this effect. Addition of L-arginine strongly enhanced this effect. Addition of D-arginine failed to mimic the effects of L-arginine. The effect of L-arginine was abolished by co-administration of NG-nitro-L-arginine. In the absence of indomethacin and L-arginine, the effect of hyperglycaemia was blunted, suggesting the formation of vasoconstrictive prostanoids. Addition of L-arginine again resulted in a significant increase in flow-induced vasodilatation. In conclusion our results suggest that increased flow-induced vasodilatation under hyperglycaemic conditions depends on an adequate supply of L-arginine to maintain sufficient formation of nitric oxide.
No takes yet. Share an insight, caveat, or question.
Wascher et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: